These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist. Baker JG; Hall IP; Hill SJ Br J Pharmacol; 2003 May; 139(2):232-42. PubMed ID: 12770928 [TBL] [Abstract][Full Text] [Related]
3. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation. Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585 [TBL] [Abstract][Full Text] [Related]
4. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727 [TBL] [Abstract][Full Text] [Related]
5. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Gherbi K; Briddon SJ; Hill SJ Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258 [TBL] [Abstract][Full Text] [Related]
6. Sarcolemmal beta-adrenoceptors determined in rat ventricular heart biopsies with (-)-[3H]CGP-12177. Brørs O; Sharikabad MN; Jørgen J Pharmacol Toxicol; 2002 Oct; 91(4):166-73. PubMed ID: 12530466 [TBL] [Abstract][Full Text] [Related]
7. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro. Disatnik MH; Sampson SR; Shainberg A Biochem Pharmacol; 1990 Sep; 40(5):1043-8. PubMed ID: 1975171 [TBL] [Abstract][Full Text] [Related]
8. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes. Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of CGP-12177-NBD: a fluorescent beta-adrenergic receptor probe. Heithier H; Jaeggi KA; Ward LD; Cantrill RC; Helmreich EJ Biochimie; 1988 May; 70(5):687-94. PubMed ID: 2901863 [TBL] [Abstract][Full Text] [Related]
10. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists. Kitagawa Y; Adachi-Akahane S; Nagao T Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230 [TBL] [Abstract][Full Text] [Related]
11. Suitability of CGP-12177 and CGP-26505 for quantitative imaging of beta-adrenoceptors. van Waarde A; Meeder JG; Blanksma PK; Bouwer J; Visser GM; Elsinga PH; Paans AM; Vaalburg W; Lie KI Int J Rad Appl Instrum B; 1992 Oct; 19(7):711-8. PubMed ID: 1356953 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors. Baker JG; Adams LA; Salchow K; Mistry SN; Middleton RJ; Hill SJ; Kellam B J Med Chem; 2011 Oct; 54(19):6874-87. PubMed ID: 21870877 [TBL] [Abstract][Full Text] [Related]
14. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Baker JG Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528 [TBL] [Abstract][Full Text] [Related]
15. Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues. Deng C; Paoloni-Giacobino A; Kuehne F; Boss O; Revelli JP; Moinat M; Cawthorne MA; Muzzin P; Giacobino JP Br J Pharmacol; 1996 Jun; 118(4):929-34. PubMed ID: 8799564 [TBL] [Abstract][Full Text] [Related]
16. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. Daly CJ; Ross RA; Whyte J; Henstridge CM; Irving AJ; McGrath JC Br J Pharmacol; 2010 Feb; 159(4):787-96. PubMed ID: 20136833 [TBL] [Abstract][Full Text] [Related]
17. [3H]CGP-12177 binding to beta-adrenoceptors of intact bovine mononuclear leukocytes. Vermeir M; Roets E; Burvenich C Arch Int Pharmacodyn Ther; 1993; 321():103-11. PubMed ID: 8100703 [TBL] [Abstract][Full Text] [Related]
18. (-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists. Affolter H; Hertel C; Jaeggi K; Portenier M; Staehelin M Proc Natl Acad Sci U S A; 1985 Feb; 82(3):925-9. PubMed ID: 2858094 [TBL] [Abstract][Full Text] [Related]
19. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta. Brahmadevara N; Shaw AM; MacDonald A Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310 [TBL] [Abstract][Full Text] [Related]
20. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding. Sarsero D; Molenaar P; Kaumann AJ; Freestone NS Br J Pharmacol; 1999 Dec; 128(7):1445-60. PubMed ID: 10602323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]